tradingkey.logo
tradingkey.logo
Search

Bruker Corp

BRKR
Add to Watchlist
60.600USD
-2.450-3.89%
Market hours 09/18, 14:07ET
9.23BMarket Cap
LossP/E TTM

More Details of Bruker Corp Company

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.

Bruker Corp Profile

Ticker SymbolBRKR
Company nameBruker Corp
IPO dateAug 04, 2000
CEOPrause (Burkhard A)
Number of employees11396
Security typeOrdinary Share
Fiscal year-endAug 04
Address40 Manning Rd
CityBILLERICA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01821-3915
Phone19786633660
Websitehttps://www.bruker.com/
Ticker SymbolBRKR
IPO dateAug 04, 2000
CEOPrause (Burkhard A)

Company Executives of Bruker Corp

Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Richard A. Packer
Mr. Richard A. Packer
Lead Independent Director
Lead Independent Director
89.17K
-1.37%
Mr. Gerald N. Herman
Mr. Gerald N. Herman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
64.97K
+13.50%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Frank H. Laukien, Ph.D.
Dr. Frank H. Laukien, Ph.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
40.42M
+0.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%
Dr. Mark Robert Munch, Ph.D.
Dr. Mark Robert Munch, Ph.D.
Executive Vice President, President of Bruker NANO Group
Executive Vice President, President of Bruker NANO Group
90.51K
+7.03%

FAQs

Who are the top five shareholders of Bruker Corp?

The top five shareholders of Bruker Corp are: Dr. Frank H. Laukien, Ph.D.

How many institutions hold shares of Bruker Corp (BRKR)?

As of 2026Q1, 929 institutions hold shares of Bruker Corp, with a combined market value of approximately 139.65M, accounting for 91.74% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -14820228.00.

What is the biggest source of revenue for Bruker Corp?

In 2026Q1, the Product business generated the highest revenue for Bruker Corp, amounting to 663.70M and accounting for 79.15% of total revenue.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.